Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial

作者
Yehyun Park,Jun Kyu Lee,Kwang Hyuck Lee,Dong‐Won Ahn,Sung Bum Kim,Seong‐Jung Kim
出处
期刊:United European gastroenterology journal [Wiley]
标识
DOI:10.1002/ueg2.70147
摘要

ABSTRACT Background and Aims Remimazolam, a new ultra‐short‐acting benzodiazepine, is a safe and effective option for procedural sedation. Nevertheless, to date, no study has directly compared remimazolam and midazolam in diagnostic upper gastrointestinal endoscopy. This study aimed to evaluate the efficacy and safety of remimazolam compared with those of midazolam in this setting. Methods This multicenter, single‐blind, randomized, positive‐control, superiority, investigator‐initiated phase III trial enrolled patients who were scheduled to undergo diagnostic upper gastrointestinal endoscopy at seven academic teaching hospitals from April 2023 to January 2024. Participants were randomly assigned to receive remimazolam or midazolam (1:1 ratio). The primary endpoint was total procedure time, defined as the duration from the first sedative administration to discharge. Results Of 133 randomized patients, 132 (remimazolam group, n = 66; midazolam group, n = 66) underwent upper endoscopy with sedation. The total procedure time was significantly shorter in the remimazolam group (30.3 vs. 48.5 min, p < 0.001). Sedation‐related times (i.e., induction, sedation, recovery, and discharge times) were also significantly shorter in the remimazolam group (all p < 0.001). The incidence of adverse events did not significantly differ between the groups; however, the incidence rates of hypotension, bradycardia, and paradoxical reactions were lower in the remimazolam group. When compared to previous sedation experiences, patient satisfaction was higher in the remimazolam group ( p < 0.001). Conclusions Compared with midazolam, the use of remimazolam in diagnostic upper gastrointestinal endoscopy allows for faster sedation induction and recovery, more rapid discharge, and higher patient satisfaction compared with previous sedation experiences, while maintaining a safety profile similar to that of midazolam. Trial registration ClinicalTrials.gov (NCT05836545)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
charles发布了新的文献求助10
刚刚
刚刚
feather完成签到,获得积分10
刚刚
刚刚
Crystal完成签到,获得积分10
刚刚
楠湘完成签到,获得积分10
刚刚
刚刚
滴滴完成签到,获得积分10
1秒前
982289172发布了新的文献求助10
1秒前
你好呀完成签到 ,获得积分10
1秒前
starry完成签到,获得积分10
2秒前
沉默诗兰完成签到,获得积分10
2秒前
tong发布了新的文献求助10
2秒前
3秒前
VV发布了新的文献求助10
3秒前
酒酒完成签到,获得积分10
3秒前
Tia完成签到 ,获得积分10
3秒前
4秒前
Dawn完成签到,获得积分10
4秒前
科研通AI6.3的应助被清辉影采纳,获得10
4秒前
在水一方的应助被fortuna采纳,获得10
4秒前
5秒前
5秒前
文艺紫菜发布了新的文献求助10
6秒前
kinsley完成签到,获得积分10
6秒前
6秒前
Lucas的应助被punch采纳,获得10
6秒前
傢誠发布了新的文献求助10
6秒前
6秒前
快乐的鱼发布了新的文献求助10
7秒前
orixero的应助被zhz采纳,获得10
7秒前
7秒前
zz发布了新的文献求助10
8秒前
所所的应助被PEITON采纳,获得10
9秒前
jun完成签到,获得积分10
9秒前
qiaobbbbb发布了新的文献求助10
10秒前
章绝施发布了新的文献求助10
10秒前
cc发布了新的文献求助10
10秒前
66666发布了新的文献求助30
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952